Healthcare provider profile · identity verified

Ashley Bradley, FNP

Nurse Practitioner · SCOTTSDALE, AZ · NPI 1245990902

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	364	55
Atorvastatin Calcium	Atorvastatin Calcium	299	69
Furosemide	Furosemide	205	41
Lisinopril	Lisinopril	201	39
Trazodone Hcl	Trazodone Hcl	194	39
Donepezil Hcl	Donepezil Hcl	181	32
Tamsulosin Hcl	Tamsulosin Hcl	175	30
Gabapentin	Gabapentin	163	28
Amlodipine Besylate	Amlodipine Besylate	152	38
Sertraline Hcl	Sertraline Hcl	151	31
Potassium Chloride	Potassium Chloride	146	32
Quetiapine Fumarate	Quetiapine Fumarate	142	25
Pantoprazole Sodium	Pantoprazole Sodium	132	27
Eliquis	Apixaban	117	22
Omeprazole	Omeprazole	106	24
Metoprolol Tartrate	Metoprolol Tartrate	99	20
Metformin Hcl	Metformin Hcl	98	19
Famotidine	Famotidine	95	18
Metoprolol Succinate	Metoprolol Succinate	93	17
Losartan Potassium	Losartan Potassium	91	14
Simvastatin	Simvastatin	89	13
Tramadol Hcl	Tramadol Hcl	89	17
Clopidogrel	Clopidogrel Bisulfate	85	12
Mirtazapine	Mirtazapine	82	15
Rosuvastatin Calcium	Rosuvastatin Calcium	81	13
Carvedilol	Carvedilol	75	14
Duloxetine Hcl	Duloxetine Hcl	72	12
Escitalopram Oxalate	Escitalopram Oxalate	72	16
Memantine Hcl	Memantine Hcl	64	suppressed
Allopurinol	Allopurinol	63	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	63	suppressed
Divalproex Sodium	Divalproex Sodium	58	suppressed
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Risperidone	Risperidone	51	11
Pravastatin Sodium	Pravastatin Sodium	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	44	suppressed
Levetiracetam	Levetiracetam	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	18
Spironolactone	Spironolactone	42	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Bupropion Xl	Bupropion Hcl	40	suppressed
Glipizide Er	Glipizide	39	suppressed
Meclizine Hcl	Meclizine Hcl	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	14
Hydroxyzine Hcl	Hydroxyzine Hcl	33	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Xarelto	Rivaroxaban	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Olanzapine	Olanzapine	30	suppressed
Finasteride	Finasteride	28	suppressed
Atenolol	Atenolol	27	suppressed
Nystatin	Nystatin	27	16
Baclofen	Baclofen	26	suppressed
Glipizide	Glipizide	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Latanoprost	Latanoprost	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Jardiance	Empagliflozin	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	15
Nifedipine Er	Nifedipine	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Prednisone	Prednisone	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Loperamide	Loperamide Hcl	20	13
Methotrexate	Methotrexate Sodium	20	suppressed
Primidone	Primidone	20	suppressed
Valsartan	Valsartan	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Azithromycin	Azithromycin	17	16
Bumetanide	Bumetanide	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Galantamine Er	Galantamine Hbr	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Topiramate	Topiramate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Linzess	Linaclotide	15	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error